Skip to main content

Table 3 In-vitro anti-bacterial activity data of complexes 14

From: Synthesis, crystallographic, spectroscopic studies and biological activity of new cobalt(II) complexes with bioactive mixed sulindac and nitrogen-donor ligands

Compounds Bordetella E. coli S. epi S. aureus Candida Saccharomyces
G- G- G+ G+ Yeast Yeast
(1) 15.3 ± 0.5 10.1 ± 0.4 21.0 ± 0.4 19 ± 1
(2) 13 ± 1 23 ± 1 11 ± 1
(3) 12 ± 2 8.5 ± 1.5 26.7 ± 0.6 21 ± 1
(4) 16 ± 2 12 ± 2 39 ± 1 25.0 ± 1.5 42 ± 1 41.12 ± 0.5
CoCl2 22 ± 2 12 ± 2 30.0 ± 0.5 11 ± 1 20.0 ± 0.7 22 ± 1
Sulindac
Genta. 30 ± 1 37 ± 1 28 ± 1 32.7 ± 0.6
Nes. 35.5 ± 0.2 40.5 ± 0.4
  1. Inhibition zone diameter (IZD) in mm, all microorganisms were resistant to DMSO. The data stated as average ± standard deviation (N = 3), the concentration of the complexes and the standards was 30 mg/5 mL in DMSO (6 g/l)
  2. — dashes indicated zero inhibition